Physician profile
Moghniuddin Mohammed
NPI 1366721417
$1,308.29
in general payments reported to CMS, 2019-2025
20 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $232 · 2023: $208 · 2024: $487 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838 · Education: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.19 |
| Education | $238.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $285.04 | 2023-2024 | Ensite, Gallant, Mitraclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.66 | 2023 | Jardiance |
| Medtronic, INC. | $134.09 | 2022-2024 | Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $126.13 | 2022-2025 | Camzyos |
| Amgen INC. | $105.29 | 2024-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $79.92 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $60.38 | 2024-2025 | Verquvo, Capvaxive |
| Heartflow, INC. | $54.78 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.72 | 2025 | |
| Pfizer INC. | $40.34 | 2022-2025 | |
| Novo Nordisk INC | $40.32 | 2025 | Wegovy |
| Irhythm Technologies, INC. | $31.06 | 2024 | Zio Monitor, Zio Xt Patch |
| Inspire Medical Systems, INC. | $26.25 | 2025 | Inspire |
| Kestra Medical Technology Services, INC. | $25.84 | 2022 | |
| Astellas Pharma US INC | $23.13 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.83 | 2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $19.13 | 2025 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $19.04 | 2024 | Xarelto |
| Scpharmaceuticals INC. | $17.96 | 2025 | |
| Abiomed | $17.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moghniuddin Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.